Effect of the change of the ancillary carboxylate bridging ligand on the SMM and luminescence properties of a series of carboxylate-diphenoxido triply bridged dinuclear ZnLn and tetranuclear Zn2Ln2 complexes (Ln = Dy, Er).

Eleven new dinuclear and tetranuclear compounds of general formulae [Zn(µ-L)(µ-X)Ln(NO3)2]·nS, [Zn2Dy2(µ3-L')2(µ-sal)2(NO3)(CH3OH)](NO3)·5CH3OH and [Zn2Er2(µ3-L')2(µ-sal)2(CH3OH)2](NO3)2·4CH3OH (X = benzoate, anthracenate, diclofenac, salicylate, 2,6-dihydroxybenzoate; Ln = Dy, Er; S = water, acetonitrile, methanol) were prepared from the N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine compartmental ligand (H2L). Complexes 1-6 and 9-11 consist of diphenoxido-carboxylate triply bridged compounds, which differ mainly in the carboxylate bridging ligand. It should be noted that the acidic character of the salicylic acid promotes, in the presence of methanol, the methoxylation of the H2L ligand thereby yielding a hemiacetal H3L', which is able to connect the Ln(iii) ions of two ZnLn dinuclear units forming the Zn2Ln2 tetranuclear complexes 7 and 8. All compounds display SMM behaviour in the presence of an external field with effective energy barriers (Ueff) as high as 61 K. Magneto-structural data for these complexes reveal that their SMM behaviour is not only significantly affected by the type of Ln(iii) ion but also by the carboxylate bridging ligand connecting the Zn(ii) and Ln(iii) ions. Photoluminescence properties have also been accomplished, showing that the ligands are able to sensitize lanthanide centred emissions in the visible and near-infrared regions with variable capacity. Moreover, the analysis of the luminescence decay curves reveals emission lifetimes in the range of few microsecond or hundreds of nanoseconds for Dy(iii)-based or Er(iii)-based luminophores, respectively.

Increasing the effective energy barrier promoted by the change of a counteranion in a Zn-Dy-Zn SMM: slow relaxation via the second excited state.

The trinuclear complex [ZnCl(µ-L)Dy(µ-L)ClZn]PF6 exhibits a single-molecule magnetic behaviour under zero field with a relatively large effective energy barrier of 186 cm(-1). Ab initio calculations reveal that the relaxation of the magnetization is symmetry-driven (the Dy(III) ion possesses a C2 symmetry) and occurs via the second excited state.

A rational design by hydrothermal methods of a tetrazolate-bridged bimetallic spin-canted antiferromagnet. Synthesis, X-ray structure and magnetic properties of [CoNi(pmtz)4] (Hpmtz- = 5-(pyrimidyl)tetrazole).

The bimetallic complex [CoNi(pmzt)4] (pmtz- = 5-(pyrimidyl)tetrazolate ligand) has been prepared by hydrothermal treatment of an equimolecular mixture of the mononuclear complexes[Co(pmtz)2(H2O)2] and [Ni(pmtz)2(H2O)2]. The structure of [CoNi(pmzt)4] consists of (4,4) square-grid-like sheets, in which Co(II) and Ni(II) metal ions are connected by pmtz(-) bridging ligands. This compound is a spin-canted antiferromagnet (weak ferromagnet) with Tc = 18 K. Although Co(II) and Ni(II) ions have different spin values, the spin-canted structure can be formed because of the accidental compensation of their magnetic moments. Both magnetic anisotropy and antisymmetric exchange interaction promote the spin canting of the compensated magnetic moments in the 3D antiferromagnetic phase. On passing from the homometallic complex, [Co2(pmzt)4], which is also a spin-canted antiferromagnet with Tc = 15 K, to the bimetallic complex, [CoNi(pmzt)4], Tc increases and the hysteresis parameters, remnant magnetization (Mr) and critical field (Hc), decrease. The increase in Tc may be a consequence of the increase of the JCoNi, whereas the decrease in Mr and Hc is probably due to the presence in [CoNi(pmzt)4] of a lower content of the highly anisotropic Co(II) ion.

Synthesis, X-ray structures and luminescence properties of three multidimensional metal-organic frameworks incorporating the versatile 5-(pyrimidyl)tetrazolato bridging ligand.

The hydrated sodium salt of the novel and versatile 5-(pyrimidyl)tetrazolato ligand (pmtz(-)), Na(pmtz).H(2)O (1), has been prepared in very mild conditions from 2-cyanopyrimidine and NaN(3). Two coordination polymers [Cd(pmtz)(2)]n (2)and [Cd(pmtz)(micro-Cl)(0.5)(micro-N(3))(0.5)(H(2)O)](n)(3), , have been synthesized from (1)under conventional or hydrothermal conditions, respectively, and fully characterized by single-crystal or powder X-ray diffraction methods. Compounds and consist of mono-dimensional polymeric chains, further stabilized by interchain pi-pi stacking and hydrogen bond interactions. Compound , containing octacoordinated Cd ions of crystallographic D(2) symmetry, exhibits neutral (4, 4) layers formed by square units of the metallacalix[4]arene type in 1,3-alternate conformation. Species , and display intense, room temperature, photoluminescence in the solid state.

[Zn(n)(polyox)(pmtz)n]: the first polyoxalate-containing coordination polymer from an unforeseen chemical rearrangement of 5-pyrimidyl-tetrazole under hydrothermal conditions.

The compound [Zn(2)(polyox)(pmtz)(2)], which has been prepared by the hydrothermal reaction of ZnCl(2) and Napmtz (5-pyrimidyl-tetrazolate), exhibits a unique 2D network with (6,3) topology, in which Zn(II) ions are connected by pmtz- and polyoxalate-bridging ligands (generated in situ from the breaking of the pmzt(-) ligand). This is the first structural report on a polyoxalate species.

Hexacyanocobaltate(III) anions as precursors of Co(II)-Ni(II) cyano-bridged multidimensional assemblies: hydrothermal syntheses, crystal and powder X-ray structures, and magnetic properties.

Three novel cyanide-bridged heterobimetallic coordination polymers have been synthesized by hydrothermal routes, in superheated water solutions, by using K3[Co(CN)6], NiCl2.6H2O, and alpha-diimine ligands: [Ni(CN)4Co(phen)] (1; phen = 1,10-phenanthroline), [Ni(CN)4Co(2,2'-bipy)] (2; 2,2'-bipy = 2,2'-bipyiridine), and [Ni(CN)4Co(2,2'-bipy)2] (3). The isostructural compounds 1 and 2 contain a two-dimensional network with Co(II) centers octahedrally coordinated by one chelating 2,2'-bipy ligand and four cyanide groups of four distinct [Ni(CN)4]2-, through crystallographically equivalent, bridging units. Compound 3 contains one-dimensional zigzag chains in which the Co(II) ion is coordinated by two chelating 2,2'-bipy ligands and two cyanides from two different [Ni(CN)4]2- units cis to each other. These compounds have been fully characterized by single-crystal or unconventional powder X-ray diffraction analyses and variable-temperature magnetic measurements.

Cyano-bridged bimetallic assemblies from hexacyanometalate, [M(CN)6](3-) (M = Mn(III) and Fe(III)), and [M(N4-macrocycle)]2+ (M=Fe(III), Ni(II) and Zn(II)) building blocks. Syntheses, multidimensional structures, and magnetic properties.

Reactions between [M(N(4)-macrocycle)](2+) (M = Zn(II) and Ni(II); macrocycle ligands are either CTH = d,l-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane or cyclam = 1,4, 8, 11-tetrazaazaciclotetradecane) and [M(CN)(6)](3-) (M = Fe(III) and Mn(III)) give rise to cyano-bridged assemblies with 1D linear chain and 2D honeycomblike structures. The magnetic measurements on the 1D linear chain complex [Fe(cyclam)][Fe(CN)(6)].6H(2)O 1 points out its metamagnetic behavior, where the ferromagnetic interaction operates within the chain and the antiferromagnetic one between chains. The Neel temperature, T(N), is 5.5 K and the critical field at 2 K is 1 T. The unexpected ferromagnetic intrachain interaction can be rationalized on the basis of the axially elongated octahedral geometry of the low spin Fe(III) ion of the [Fe(cyclam)](3+) unit. The isostructural substitution of [Fe(CN)(6)](3-) by [Mn(CN)(6)](3-) in the previously reported complex [Ni(cyclam)](3)[Fe(CN)(6)](2).12H(2)O 2 leads to [Ni(cyclam)](3)[Mn(CN)(6)](2).16 H(2)O 3, which exhibits a corrugated 2D honeycomblike structure and a metamagnetic behavior with T(N) = 16 K and a critical field of 1 T. In the ferromagnetic phase (H > 1 T) this compound shows a very important coercitive field of 2900 G at 2 K. Compound [Ni(CTH)](3)[Fe(CN)(6)](2).13H(2)O 4, C(60)H(116)Fe(2)N(24)Ni(3)O(13), monoclinic, A 2/n, a = 20.462(7), b = 16.292(4), c = 27.262(7) A, beta = 101.29(4) degrees, Z = 4, also has a corrugated 2D honeycomblike structure and a ferromagnetic intralayer interaction, but, in contrast to 2 and 3, does not exhibit any magnetic ordering. This fact is likely due to the increase of the interlayer separation in this compound. ([Zn(cyclam)Fe(CN)(6)Zn(cyclam)] [Zn(cyclam)Fe(CN)(6)].22H(2)O.EtOH) 5, C(44)H(122)Fe(2)N(24)O(23)Zn(3), monoclinic, A 2/n, a = 14.5474(11), b = 37.056(2), c = 14.7173(13) A, beta = 93.94(1) degrees, Z = 4, presents an unique structure made of anionic linear chains containing alternating [Zn(cyclam)](2+) and [Fe(CN)(6)](3)(-) units and cationic trinuclear units [Zn(cyclam)Fe(CN)(6)Zn(cyclam)](+). Their magnetic properties agree well with those expected for two [Fe(CN)(6)](3-) units with spin-orbit coupling effect of the low spin iron(III) ions.

A rational design for imidazolate-bridged linear trinuclear compounds from mononuclear copper(II) complexes with 2-[((imidazol-2-ylmethylidene)amino)ethyl]pyridine (HL): syntheses, structures, and magnetic properties of [Cu(L)(hfac)M(hfac)2Cu(hfac)(L)] (M = ZnII, CuII, MnII).

Two mononuclear copper(II) complexes with the unsymmetrical tridentate ligand 2-[((imidazol-2-ylmethylidene)amino)ethyl]pyridine (HL), [Cu(HL)(H2O)](ClO4)2.2H2O (1) and [Cu(HL)Cl2] (2), have been prepared and characterized. The X-ray analysis of 2 revealed that the copper(II) ion assumes a pentacoordinated square pyramidal geometry with an N3Cl2 donor set. When 1 and 2 are treated with an equimolecular amount of potassium hydroxide, the deprotonation of the imidazole moiety promotes a self-assembled process, by coordination of the imidazolate nitrogen atom to a Cu(II) center of an adjacent unit, leading to the polynuclear complexes [[Cu(L)(H2O)](ClO4)]n (3) and [[Cu(L)Cl].2H2O]n (4). Variable-temperature magnetic data are well reproduced for one-dimensional infinite regular chain systems with J = -60.3 cm(-1) and g = 2.02 for 3 and J = -69.5 cm(-1) and g = 2.06, for 4. When 1 is used as a "ligand complex" for [M(hfac)2] (M = Cu(II), Ni(II), Mn(II), Zn(II)) in a basic medium, only the imidazolate-bridged trinuclear complexes [Cu(L)(hfac)M(hfac)2Cu(hfac)(L)] (M = Zn(II), Cu(II)) (5, 6) can be isolated. Nevertheless, the analogous complex containing Mn(II) as the central metal (7) can be prepared from the precursor [Cu(HL)Cl2] (2). All the trinuclear complexes are isostructural. The structures of 5 and 6 have been solved by X-ray crystallographic methods and consist of well-isolated molecules with Ci symmetry, the center of symmetry being located at the central metal. Thus, the copper(II) fragments are in trans positions, leading to a linear conformation. The magnetic susceptibility data (2-300 K), which reveal the occurrence of antiferromagnetic interactions between copper(II) ions and the central metal, were quantitatively analyzed for symmetrical three-spin systems to give the coupling parameters JCuCu = -37.2 and JCuMn = -3.7 cm(-1) with D = +/-0.4 cm(-1) for 6 and 7, respectively. These magnetic behaviors are compared with those for analogous systems and discussed on the basis of a localized-orbital model of exchange interactions.

Helical-chain copper(II) complexes and a cyclic tetranuclear copper(II) complex with single syn-anti carboxylate bridges and ferromagnetic exchange interactions.

Tridentate Schiff-base carboxylate-containing ligands, derived from the condensation of 2-imidazolecarboxaldehyde with the amino acids beta-alanine (H2L1) and 2-aminobenzoic acid (H2L5) and the condensation of 2-pyridinecarboxaldehyde with beta-alanine (HL2), D,L-3-aminobutyric acid (HL3), and 4-aminobutyric acid (HL4), react with copper(II) perchlorate to give rise to the helical-chain complexes [[Cu(mu-HL1)(H2O)](ClO4)]n (1), [[Cu(mu-L2)(H2O)](ClO4).2H2O]n (2), and [[Cu(mu-L3)(H2O)](ClO4).2H2O]n (3), the tetranuclear complex [[Cu(mu-L4)(H2O)](ClO4)]4 (4), and the mononuclear complex [Cu(HL5)(H2O)](ClO4).1/2H2O (5). The reaction of copper(II) chloride with H2L1 leads not to a syn-anti carboxylate-bridged compound but to the chloride-bridged dinuclear complex [Cu(HL1)(mu-Cl)]2 (6). The structures of these complexes have been solved by X-ray crystallography. In complexes 1-4, roughly square-pyramidal copper(II) ions are sequentially bridged by syn-anti carboxylate groups. Copper(II) ions exhibit CuN2O3 coordination environments with the three donor atoms of the ligand and one oxygen atom belonging to the carboxylate group of an adjacent molecule occupying the basal positions and an oxygen atom (from a water molecule in the case of compounds 1-3 and from a perchlorate anion in 4) coordinated in the apical position. Therefore, carboxylate groups are mutually cis oriented and each syn-anti carboxylate group bridges two copper(II) ions in basal-basal positions with Cu...Cu distances ranging from 4.541 A for 4 to 5.186 A for 2. In complex 5, the water molecule occupies an equatorial position in the distorted octahedral environment of the copper(II) ion and the Cu-O carboxylate distances in axial positions are very large (>2.78 A). Therefore, this complex can be considered as mononuclear. Complex 6 exhibits a dinuclear parallel planar structure with Ci symmetry. Copper(II) ions display a square-pyramidal coordination geometry (tau = 0.06) for the N2OCl2 donor set, where the basal coordination sites are occupied by one of the bridging chlorine atoms and the three donor atoms of the tridentate ligand and the apical site is occupied by the remaining bridging chlorine atom. Magnetic susceptibility measurements indicate that complexes 1-4 exhibit weak ferromagnetic interactions whereas a weak antiferromagnetic coupling has been established for 6. The magnetic behavior can be satisfactorily explained on the basis of the structural data for these and related complexes.

Synthesis and characterization of novel palladium(II) complexes of bis(thiosemicarbazone). Structure, cytotoxic activity and DNA binding of Pd(II)-benzyl bis(thiosemicarbazonate).

The preparation of palladium(II) complexes of 3,5-diacyl-1,2,4-triazole bis(thiosemicarbazone) (H2L2), 2,6-diacylpyridine bis(thiosemicarbazone) (H2L3) and benzyl bis(thiosemicarbazone) (H2L4) is described. The new complexes [PdCl2(H2L2)] (1), [PdCl2(H2L3)] (2) and [PdL4].DMF (3) have been characterized by elemental analyses and spectroscopic studies (IR, 1H NMR and UV-Vis). The crystal and molecular structure of PdL4.DMF (L = bideprotonated form of benzyl bis(thiosemicarbazone)) has been determined by single-crystal X-ray diffraction: green triclinic crystal, a = 10.258(5), b = 10.595(5), c = 11.189(5) A, alpha = 97.820(5), beta = 108.140(5), gamma = 105.283(5) degrees, space group P1, Z = 1. The palladium atom is tetracoordinated by four donor atoms (SNNS) from L4 to form a planar tricyclic ligating system. The testing of the cytotoxic activity of compound 3 against several human, monkey and murine cell lines sensitive (HeLa, Vero and Pam 212) and resistant to cis-DDP (Pam-ras) suggests that compound 3 might be endowed with important antitumor properties since it shows IC50 values in a microM range similar to those of cis-DDP [cis-diamminedichloroplatinum(II)]. Moreover, compound 3 displays notable cytotoxic activity in Pam-ras cells resistant to cis-DDP (IC50 values of 78 microM versus 156 microM, respectively). On the other hand, the analysis of the interaction of this novel Pd-thiosemicarbazone compound with DNA secondary structure by means of circular dichroism spectroscopy indicates that it induces on the double helix conformational changes different from those induced by cis-DDP.

Copper(I)-Purine-Phosphine Complexes. Syntheses and Molecular Structures of [Cu(2)(&mgr;-HL(1))(2)(&mgr;-dppm)(eta(1)-dppm)(2)] and {[Cu(3)(&mgr;(3)-Cl)(2)(&mgr;-dppm)(3)][Cu(HL(2))(2)]} (H(2)L(1) = 8-Mercaptotheophylline and H(2)L(2) = 8-Ethyl-3-methylxanthine).

The syntheses and molecular structures of two novel polynuclear copper(I)-purine-phosphine complexes are reported. The first one is a dinuclear [Cu(2)(&mgr;-HL(1))(2)(&mgr;-dppm)(eta(1)-dppm)(2)] complex (H(2)L(1) is 8-mercaptotheophylline). The compound crystallizes in the triclinic system, space group P&onemacr;, with cell constants a = 12.342(5) Å, b = 15.255(5) Å, c = 24.972(5) Å, alpha = 74.31(2) degrees, beta = 78.62(2) degrees, gamma = 72.51(2) degrees, and Z = 2. The structure of this complex exhibits as the most important feature the simultaneous presence of eta(1)-terminal and eta(2)-bridging dppm ligands, which is first here described for a copper complex. This complex is also of interest because of its reversible photochromic behavior in the solid state. The second compound is an ionic {[Cu(3)(&mgr;(3)-Cl)(2)(&mgr;-dppm)(3)][Cu(HL(2))(2)]} complex (H(2)L(2) is 8-ethyl-3-methylxanthine), which crystallizes in the monoclinic system, space group P2(1)/n, with cell constants a = 15.829(6) Å, b = 22.801(7) Å, c = 28.569(6) Å, beta = 97.65(4) degrees, and Z = 6. The structure of this complex consists of trinuclear copper(I) cations and mononuclear [Cu(purine)(2)](-) anions, exhibiting a linear stereochemistry. As far as we know, this compound represents the first example of a copper(I)-purine complex whose structure has been determined by X-ray crystallography.

The (8-thiotheophyllinate) (triphenylphosphine) gold (I), (tTAuP): a new gold complex as an anticancer agent.

In continuous Friend leukemia cell exposure to tTAuP, the IC50 was 0.2 microM whereas in cells exposed 15 or 60 min to tTAuP followed by 72 h in drug-free medium the IC50 was 2.2 and 1.3 microM respectively. A combination of tTAuP and cisplatin (CDDP) is shown to be more active than either agent alone. Intracellular accumulation studies analysed by SXRF have shown that to achieve a cytotoxic effect, large concentrations of gold are necessary to accumulate in both the nuclear and cytoplasmic fraction. However, at cytostatic doses (1 microM), tTAuP has no effect on the cell cycle but does affect DNA synthesis. At a higher dose, greater than that necessary to induce cytotoxicity, it produces DNA damage, as observed by alkaline elution method. When cells were exposed to toxic doses of tTAuP (10 microM) in the presence of albumin, cytotoxicity was significantly reduced. Similar results were obtained when cells were co-treated with L-cysteine, dithiothreitol or reduced gluthatione. Reduced cytotoxic effect can be related to the interaction with free thiol groups. According to these data it is concluded that tTAuP is highly effective in vitro; whether it is active in vivo remains to be determined.

Intracellular accumulation and cytotoxic effect of (8-thiotheophyllinate) (triphenylphosphine) gold(I) in Friend leukemia cells.

Following continuous exposure to tTAuP in medium containing 10% fetal calf serum (FCS), cells resistant to doxorubicin (DOX-RFLC) were 3 fold more resistant to tTAuP than its sensitive counterpart (FLC). Moreover, FLC were 100 fold more sensitive to tTAuP when the cells were grown in the absence of FCS but in the presence of synthetic medium (BMS). When the cytotoxic effect was measured after short-term exposure (60 min) followed by 72 hr incubation in drug-free medium, unexpectedly, DOX-RFLC were 8 fold more sensitive [ID50 = 1.5 microM] than FLC [ID50 = 12 microM] to tTAuP. When FLC were exposed 60 min at different temperatures (4, 25 or 37 degrees C) to tTAuP prior to 72 hr incubation in drug free medium, the ID50 was achieved at 20, 13 and 3 microM respectively). In contrast, when DOX-RFLC were treated in similar conditions, the cytotoxic activity of tTAuP did not vary following exposure at 4, 25 or 37 degrees C. Although the mechanism of action of gold compounds is still unknown we have assumed that tTAuP cytotoxicity is related to the ease with which it is accumulated. This assumption was supported by the analysis of tTAuP incorporation by SXRF. The results reported here show that tTAuP accumulates rapidly in the cell and is distributed in the cytoplasmic and the nuclear fractions. It is suggested that accumulation is mediated by passive diffusion. However, the detection of gold binding to DNA in complexes resistant to solvent treatments suggests that interaction with macromolecules can be mediated by the formation of covalently bound complexes.